APA (7th ed.) Citation

S, A., T, M., N, K., T, I., & K, S. (2025). Utility of the Clinical Assessment Scale for Autoimmune Encephalitis (CASE) Score to Define Relapse in the Scarcity of Biomarker Footprints in Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis: A Case Report. Cureus, 17(9), e93405. https://doi.org/10.7759/cureus.93405

Chicago Style (17th ed.) Citation

S, Adachi, Matsuda T, Kanazawa N, Iizuka T, and Shiga K. "Utility of the Clinical Assessment Scale for Autoimmune Encephalitis (CASE) Score to Define Relapse in the Scarcity of Biomarker Footprints in Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis: A Case Report." Cureus 17, no. 9 (2025): e93405. https://doi.org/10.7759/cureus.93405.

MLA (9th ed.) Citation

S, Adachi, et al. "Utility of the Clinical Assessment Scale for Autoimmune Encephalitis (CASE) Score to Define Relapse in the Scarcity of Biomarker Footprints in Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis: A Case Report." Cureus, vol. 17, no. 9, 2025, p. e93405, https://doi.org/10.7759/cureus.93405.